Table 7 CSF findings at the time of the first LP and at the time of follow-up
Units | First LP ever | Follow-up LPs, first LP/event | |
|---|---|---|---|
Pleocytosis, all acute attacks | Samples | 44/79 (55.7%) | 10/23 (43.5%) |
Pleocytosis, acute MY | Samples | 26/31 (83.9%) | 6/9 (66.7%) |
Pleocytosis, acute ON | Samples | 12/39 (30.8%) | 3/11 (27.3%) |
Pleocytosis, acute BRAIN | Samples | 5/7 (71.4%) | 1/3 (33.3%) |
OCB, all acute attacks | Samples | 7/73 (9.6%) | 2/23 (8.7%) |
OCB, acute MY | Samples | 1/27 (3.7%) | 2/10 (20%)# |
OCB, acute ON | Samples | 3/38 (7.9%) | 0/10 (0%) |
OCB, acute BRAIN | Samples | 2/7 (28.6%) | 0/3 (0%) |
IgG-IF > 10%, all acute attacks | Samples | 4/63 (6.3%) | 3/24 (12.5%) |
IgG-IF > 10%, acute MY | Samples | 2/26 (7.7%) | 0/9 (0%) |
IgG-IF > 10%, acute ON | Samples | 2/31 (6.5%) | 0/9 (0%) |
IgG-IF > 10%, acute BRAIN | Samples | 0/5 (0%) | 0/3 (0%) |
QAlb > Qlim(Alb), all acute attacks | Samples | 35/65 (53.8%) | 7/23 (30.4%) |
QAlb > Qlim(Alb), acute MY | Samples | 16/26 (61.5%) | 6/10 (60%) |
QAlb > Qlim(Alb), acute ON | Samples | 14/33 (42.4%) | 1/10 (10%) |
QAlb > Qlim(Alb), acute BRAIN | Samples | 4/5 (80%) | 0/3 (0%) |
CSF TP elevated, all acute attacks | Samples | 33/70 (47.1%) | 9/23 (39.1%) |
CSF TP elevated, acute MY | Samples | 15/27 (55.6%) | 6/10 (60%) |
CSF TP elevated, acute ON | Samples | 14/37 (37.8%) | 1/10 (10%) |
CSF TP elevated, acute BRAIN | Samples | 4/5 (80%) | 2/3 (66.7%) |
CSF l-lactate elevated, all acute attacks | Samples | 14/52 (26.9%) | 2/13 (15.4%) |
CSF l-lactate elevated, acute MY | Samples | 9/21 (42.9%) | 1/5 (20%) |
CSF l-lactate elevated, acute ON | Samples | 5/28 (17.9%) | 1/8 (12.5%) |
CSF l-lactate elevated, acute BRAIN | Samples | 0/3 (0%) | 0/0 (0%) |
Time since attack onset, acute LPs | Days | 7 (0-34) | 9.5 (0-28) |